Current Assets
Accounts Receivable
Merck & Co. Accounts Receivable increased by 3.7% to $12.21B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 13.2%, from $10.79B to $12.21B. Over 5 years (FY 2020 to FY 2025), Accounts Receivable shows an upward trend with a 11.6% CAGR.
Analysis
StatementBalance Sheet Statement
SectionCurrent Assets
CategoryEfficiency
SignalContext dependent
VolatilityModerate
First reportedQ1 2013
Last reportedQ1 2026May 4, 2026
How to read this metric
Rapid growth relative to revenue may indicate collection issues, while stable or declining levels relative to revenue suggest efficient cash conversion.
Detailed definition
This represents the total amount owed to the company by customers for goods or services delivered, net of the allowance...
Peer comparison
Standard metric; peers with shorter payment terms will typically show lower accounts receivable relative to sales.
Metric ID:
accounts_receivable_netHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $7.84B | $8.57B | $9.23B | $9.83B | $9.64B | $9.48B | $9.45B | $10.42B | $11.03B | $10.39B | $10.35B | $11.37B | $11.64B | $11.38B | $10.28B | $10.79B | $11.85B | $12.12B | $11.78B | $12.21B |
| QoQ Change | — | +9.3% | +7.7% | +6.5% | -1.9% | -1.7% | -0.3% | +10.2% | +5.9% | -5.8% | -0.4% | +9.8% | +2.4% | -2.2% | -9.7% | +5.0% | +9.8% | +2.3% | -2.8% | +3.7% |
| YoY Change | — | — | — | — | +23.0% | +10.6% | +2.4% | +6.0% | +14.4% | +9.6% | +9.5% | +9.1% | +5.5% | +9.5% | -0.7% | -5.1% | +1.8% | +6.5% | +14.6% | +13.2% |
Range$7.84B – $12.21B
CAGR+9.8%
Avg YoY Growth+8.1%
Median YoY Growth+9.3%
Accounts Receivable at Other Companies
Frequently Asked Questions
- What is Merck & Co.'s accounts receivable?
- Merck & Co. (MRK) reported accounts receivable of $12.21B in Q1 2026.
- How has Merck & Co.'s accounts receivable changed year-over-year?
- Merck & Co.'s accounts receivable increased by 13.2% year-over-year, from $10.79B to $12.21B.
- What is the long-term trend for Merck & Co.'s accounts receivable?
- Over 5 years (2020 to 2025), Merck & Co.'s accounts receivable has grown at a 11.6% compound annual growth rate (CAGR), from $6.8B to $11.78B.
- What does accounts receivable mean?
- The total amount of money customers owe the company for products or services already delivered.